Top 10 Most Popular Chinese Vaccine For Rabies Prophylaxis Brands

May 14, 2024

Rabies is a deadly virus that can be transmitted through the bite of an infected animal. The most effective way to prevent rabies is through vaccination. The vaccine for rabies prophylaxis is safe and highly effective in providing protection against the virus. It is recommended for individuals at high risk of exposure, such as veterinarians, animal control workers, and travelers to rabies-endemic areas. By getting vaccinated, you can protect yourself and your loved ones from this deadly disease.

HDCV
Rabipur
Changchun Zhuoyi Biological Co., Ltd
Vero Cell

HDCV

Establishment time : HDCV was established in 2005.

website : www.hdcv.com

Main Product : Industrial valves and control systems.

Company Profile

HDCV is a leading provider of high-quality industrial valves and control systems, serving customers worldwide with innovative solutions for their fluid control needs.

Rabipur

Establishment time : 1984

website : www.rabipur.com

Main Product : Rabies vaccine

Company Profile

Rabipur is a leading manufacturer of rabies vaccine, established in 1984. With a large presence in the global market, Rabipur competes with other manufacturers to provide high-quality vaccines for the prevention of rabies. Visit www.rabipur.com for more information.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Vero Cell

Establishment time : 2012

website : www.verocell.com

Main Product : Cell culture products and services

Company Profile

Vero Cell is a leading provider of cell culture products and services for the biotechnology and pharmaceutical industries. Founded in 2012, we have grown to become a medium-sized company with a strong presence in the market. Our products are known for their high quality and reliability, making us a trusted partner for our customers. Visit our website at www.verocell.com for more information.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326